… Continuous infusion of ceftazidime is a cost-effective alternative to intermittent infusion for
nosocomial pneumonia … for empiric treatment of nosocomial pneumonia, the challenge in the …

… of continuous versus intermittent ceftazidime in ICU patients with nosocomial pneumonia. …
either as a 3 g/day continuous infusion (CI) or an intermittent infusion (II) of 2 g every 8 h. In …

… infusion in patients with nosocomial pneumonia (NP) results in higher cure rate and improved
mortality compared to intermittent infusion… of extended/continuous infusion of antimicrobial …

… Some studies have found that the administration of carbapenems by continuous infusion …
of meropenem by continuous infusion administration (CI) or by intermittent infusion (II) for …

… nosocomial pneumonia. Little is known about the intrapulmonary pharmacokinetics (PK) of
meropenem when administered by continuous infusion … patients with nosocomial pneumonia. …

… Administration of piperacillin/tazobactam by continuous infusion may have more clinical
efficacy than administration by intermittent infusion for the treatment of nosocomial pneumonia. …

… The administration of 4 g ceftazidime in continuous infusion in critically ill patients with
severe nosocomial pneumonia provides concentrations in excess of the minimal inhibitory …

… continuous infusion (CI) has, therefore, been advocated for difficult-to-treat situations 2 and
tested in several indications including nosocomial pneumonia… CI in nosocomial pneumonia in …

… meropenem by continuous infusion (1 g over 360 min every 6 h), the other by intermittent
infusion (1 … Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable …

… meropenem infusions in patients with nosocomial pneumonia is … meropenem infusions in
the treatment of nosocomial pneumonia. … infusions in adult patients who had been treated for …